4//SEC Filing
Lis William 4
Accession 0001213900-22-035570
CIK 0001788028other
Filed
Jun 27, 8:00 PM ET
Accepted
Jun 28, 4:01 PM ET
Size
7.4 KB
Accession
0001213900-22-035570
Insider Transaction Report
Form 4
Lis William
DirectorChief Executive Officer
Transactions
- Sale
Voting Common Stock
2022-06-27$2.08/sh−24,743$51,404→ 40,486 total - Sale
Voting Common Stock
2022-06-24$2.02/sh−24,743$50,030→ 65,229 total
Footnotes (3)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.88 to $2.24, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.86 to $2.30, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
Documents
Issuer
Jasper Therapeutics, Inc.
CIK 0001788028
Entity typeother
Related Parties
1- filerCIK 0001574558
Filing Metadata
- Form type
- 4
- Filed
- Jun 27, 8:00 PM ET
- Accepted
- Jun 28, 4:01 PM ET
- Size
- 7.4 KB